Xcout Intel
Vaderis Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Vaderis Therapeutics among biotechnology companies — ranked by similarity to what Vaderis Therapeutics actually does, not by market-cap band.
Subscribe to see Vaderis Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Vaderis Therapeutics
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Vaderis Therapeutics at a glance
Vaderis Therapeutics is a biotechnology company headquartered in Switzerland. Its most recent funding round, Series B, raised $152.5M in August 2026. Xcout tracks 1 named person at Vaderis Therapeutics, including Azmi Nabulsi (President and Chief Executive Officer).
Vaderis Therapeutics leadership
- Azmi NabulsiPresident and Chief Executive Officer
Vaderis Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $152.5M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Vaderis Therapeutics competitors
Ranked by semantic similarity — how close each company is to Vaderis Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Biotech
Granite Bio is a biotechnology company headquartered in Basel, Switzerland. It is developing first-in-class therapies by targeting fundamentals of biology and debuted with $100 million of capital.
Similar biotechnology company
VAXIMM AG is a biotech company headquartered in Basel, Switzerland, that focuses on developing a new class of cytotoxic immunotherapies and clinical-stage targeted treatments through its subsidiaries.
Similar biotechnology company
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
Biotech
Windward Bio is a clinical-stage biotechnology and drug development company headquartered in Basel, Switzerland. It is committed to improving outcomes for people living with serious immunological diseases through its deep discovery, development, and commercialization expertise.
Similar biotechnology company
Endogena Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Zürich, Switzerland, that discovers and develops first-in-class endogenous regenerative medicines to repair tissues.
Biotech
Amporin Pharmaceuticals AG is a Swiss biotechnology company founded in Basel in 2024. The firm focuses on developing a new class of small-molecule drugs designed to target toxic membrane mechanisms.
Biotech
TECregen AG is a biotechnology company headquartered in Basel, Switzerland. The company is dedicated to advancing immuno-rejuvenation through the development of next-generation therapies designed to regenerate the thymus.
Similar biotechnology company
Polyneuron Pharmaceuticals is a venture-backed biotech and life sciences company headquartered in Basel, Switzerland. Founded in 2014, the company is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases.
Similar biotechnology company
GlycoEra AG is a biotechnology company focused on advancing glycan-mediated therapy through game-changing protein engineering. Headquartered in Wädenswil, Switzerland, the company also maintains an office in Newton, Massachusetts.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Similar biotechnology company
Allegria Therapeutics is a Swiss biotech company founded in Basel in 2023 that targets mast cells to redefine the treatment of allergic and inflammatory diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Vaderis Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Vaderis Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →